ConductScience.org, home

Paper8551601

Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells.

Carrillo A and 1 other. J Virol, 1996. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells. Papers, record 8551601. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551601

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells.
PubMed
Journal
J Virol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.13
iCite
Revised in PubMed
2020-07-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carrillo AA
2Ratner LL

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV Envelope Protein gp120Major topic
HIV-1Major topic
Peptide FragmentsMajor topic
T-LymphocytesMajor topic
Amino Acid Sequence
Cloning, Molecular
Gene Products, env
Humans
Kinetics
Membrane Fusion
Molecular Sequence Data
Mutation
Recombinant Fusion Proteins
Tumor Cells, Cultured
Vaccinia virus
beta-Galactosidase

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI07172-15NIAID NIH HHSUnited StatesPubMedPubMed
AI24745NIAID NIH HHSUnited StatesR01AI024745PubMed and NIHNIH RePORTER

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11920616Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.J Virol1991https://conductscience.org/library/papers/1920616PubMed
22234068Product review. New mammalian expression vectors.Nature1990https://conductscience.org/library/papers/2234068PubMed
31942255Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.J Virol1991https://conductscience.org/library/papers/1942255PubMed
41727490The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.J Virol1992https://conductscience.org/library/papers/1727490PubMed
51546447V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.Virology1992https://conductscience.org/library/papers/1546447PubMed
61548783Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.J Virol1992https://conductscience.org/library/papers/1548783PubMed
73095828Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3095828PubMed
83257102In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.J Virol1988https://conductscience.org/library/papers/3257102PubMed
92452447Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2452447PubMed
102547987Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120.J Virol1989https://conductscience.org/library/papers/2547987PubMed
112771954Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2771954PubMed
122355006
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
J Biol Chem1990https://conductscience.org/library/papers/2355006PubMed
138497073A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism.J Virol1993https://conductscience.org/library/papers/8497073PubMed
148497077Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.J Virol1993https://conductscience.org/library/papers/8497077PubMed
158510212Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.J Virol1993https://conductscience.org/library/papers/8510212PubMed
168317093Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.Virology1993https://conductscience.org/library/papers/8317093PubMed
177686374Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.AIDS1993https://conductscience.org/library/papers/7686374PubMed
187687303Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.J Virol1993https://conductscience.org/library/papers/7687303PubMed
198249306Identification of HIV1 determinants for T lymphoid cell line infection.Virology1993https://conductscience.org/library/papers/8249306PubMed
207504741Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.J Virol1994https://conductscience.org/library/papers/7504741PubMed

See all 48 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
32295903Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.J Virol2020https://conductscience.org/library/papers/32295903PubMed
30842322A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.J Virol2019https://conductscience.org/library/papers/30842322PubMed
27143130Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.Retrovirology2016https://conductscience.org/library/papers/27143130PubMed
25313689
Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.
PLoS One2014https://conductscience.org/library/papers/25313689PubMed
25287422Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Retrovirology2014https://conductscience.org/library/papers/25287422PubMed
24862329Bioinformatic analysis of HIV-1 entry and pathogenesis.Curr HIV Res2014https://conductscience.org/library/papers/24862329PubMed
23369442Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Retrovirology2013https://conductscience.org/library/papers/23369442PubMed
21752271Genotypic prediction of HIV-1 subtype D tropism.Retrovirology2011https://conductscience.org/library/papers/21752271PubMed
21569409Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.Retrovirology2011https://conductscience.org/library/papers/21569409PubMed
20860805Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.Retrovirology2010https://conductscience.org/library/papers/20860805PubMed
20573813Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.J Virol2010https://conductscience.org/library/papers/20573813PubMed
18480460R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.J Virol2008https://conductscience.org/library/papers/18480460PubMed
17329448Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.J Clin Microbiol2007https://conductscience.org/library/papers/17329448PubMed
17202224Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.J Virol2007https://conductscience.org/library/papers/17202224PubMed
17079307Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection.J Virol2007https://conductscience.org/library/papers/17079307PubMed
16378977Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.J Virol2006https://conductscience.org/library/papers/16378977PubMed
14990699Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor.J Virol2004https://conductscience.org/library/papers/14990699PubMed
14671134
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
J Virol2004https://conductscience.org/library/papers/14671134PubMed
12768015A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.J Virol2003https://conductscience.org/library/papers/12768015PubMed
11413305Target cell populations of human immunodeficiency virus type 1 in peripheral blood lymphocytes with different chemokine receptors at various stages of disease progression.J Virol2001https://conductscience.org/library/papers/11413305PubMed

See all 31 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8551601

GET https://conductscience.org/api/papers/v1/8551601/references?page=2